Article info
Neurodegeneration
Original research
Anti-Aβ agents for mild to moderate Alzheimer's disease: systematic review and meta-analysis
- Correspondence to Professor Nenggui Xu, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; ngxu8018{at}163.com
Citation
Anti-Aβ agents for mild to moderate Alzheimer's disease: systematic review and meta-analysis
Publication history
- Received April 14, 2020
- Revised June 1, 2020
- Accepted July 8, 2020
- First published October 12, 2020.
Online issue publication
December 11, 2020
Article Versions
- Previous version (16 November 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.